Trial Profile
Single-Center, Double-Blind, Placebo-Controlled, Single-Dose, 4-Period Crossover, Drug-Alcohol Interaction Study in Lemborexant in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jun 2022
Price :
$35
*
At a glance
- Drugs Lemborexant (Primary) ; Alcohol
- Indications Circadian rhythm sleep disorders; Insomnia; Sleep apnoea syndrome
- Focus Pharmacodynamics
- Sponsors Eisai Inc
- 01 Jun 2022 Results assessing effects of lemborexant and alcohol coadministration on postural stability, cognitive performance, and the pharmacokinetics, safety, and tolerability of lemborexant published in the Journal of Psychopharmacology
- 16 Oct 2018 Status changed from recruiting to completed.
- 19 Jul 2018 Planned End Date changed from 18 Jun 2018 to 12 Sep 2018.